Tagged with EALTH

Czech Republic Martin Balada and Kateřina Podrazilová from the Association of Health Insurance Companies of the Czech Republic (SZP ČR) give a thorough insight into the current dialogues surrounding pricing and reimbursement, set to deeply impact access to highly innovative and orphan drugs in the country. Furthermore, they evaluate the uniqueness of…

Hungary Dr Ildikó Horvath, Hungary’s State Secretary for Health explains her role and shares insights on the key health trends in Hungary, the government’s top priority in improving healthcare, the importance of digitalization, and efforts made to close the life expectancy gap with Europe.   Hungary is on average five years…

USA Carla Smith looks at the three vital components behind successful strategic alliances in US healthcare:disruption,  data-driven demands and convenient care delivery.   Throughout my career, to bring positive and lasting change to the health sector, I’ve brokered more collaborative efforts than I can count. Strategic alliances between health leaders, nonprofit…

Romania Healthcare spending in Romania in comparison to the EU average. Made with Visme Infographic Maker   Romania spends the least on healthcare as a proportion of its GDP in the entire EU. Made with Visme Infographic Maker     Out of pocket healthcare spending in Romania as a proportion of…

Hungary Veronika Ferencz, general manager of Exeltis Hungary, gives an update on the recent activies and achievement of the affiliate since her last PharmaBoardroom interview in 2016. Furthermore, Ferencz goes on to highlight how the upcoming launch of the company’s first innovative product Slinda® is a very significant step in its…

UAE Rahja Daher, head of the Health Group for the Swiss Business Council (SBC) Dubai & Northern Emirates discusses the association’s formation, priorities and major challenges, as well as an outline of the healthcare and life sciences sector in the UAE at large.   Dubai is by far still the hub…

Czech Republic Štěpán Svačina, Chairman of the Czech Medical Association (CzMA), gives insights into the challenges that the Czech Republic faces in bringing change to the life sciences infrastructure. Whilst pointing out the areas in which the country is seeing positive advances — efficient communication with key personalities in healthcare such as…

Hungary Prof. Éva Szökő, president of the Hungarian Society for Pharmaceutical Sciences (MGYT), shares her insights on the activities of the society, its collaboration with institutions and industry players in the area of prevention, adherence, public health awareness, translational research, and its future outlook.   [Hungarian] patients are suspicious of prescribed…

Czech Republic The Czech Republic’s Minister of Health,  Adam Vojtěch, is the youngest in the country’s history and has set out an ambitious reform programme to improve the state of the Czech healthcare system.   In my office, I will actively seek to fulfil the key points of my election program –…

Hungary Dr. Péter Ofner, Former Director of the Gottsegen Hungarian Insititute of Cardiology, shares his insights on the cardiological capabilities of the institute, the epidemiological profile of the country, the collaborations with industry players, and outlooks for the future of this field as well as the country.   Hungary is a…

GSK In conversation at the FT Global Pharmaceutical and Biotechnology Conference in London,* an energetic Emma Walmsley discussed the strategic and cultural shifts she has implemented in her two and a half years as CEO of iconic British firm GSK, the increasingly important intersection between technology and pharma, and countering the…

India The Indian Government has had a busy 2019 so far with respect to healthcare regulation. From passing the controversial National Medical Commission Bill, 2019 through Parliament to releasing a digital health blueprint, the Indian Government has had a very clear vision for the future of healthcare in India. That vision…